Some people who dose received messenger RNA Are prone to inflammation of the heart, including myocarditis or pericarditis. Even if these cases are fairly rare in areas where they have been reported, the risk of their occurrence is low compared to the benefits provided by the said vaccines. After these cases emerged, Canadian health officials recently made recommendations.
“We are closely monitoring the development of the situation”
The National Advisory Committee on Immunization (NACI) recommends that people who have developed pericarditis or myocarditis after their first dose of vaccine “to wait until more information is available before receiving their second dose”. In a statement, Dr. Shelley DixThe chairman of the committee said: “We are closely monitoring the development of rare cases of myocarditis or pericarditis after administration of mRNA vaccine in young people. NACI is encouraged that the clinical picture appears mild and resolves quickly. go”. In addition, the NACI recommended that people who wish to receive the vaccine mRNA be aware “Very rare risk of myocarditis or pericarditis after vaccination”.
Note that the Canadian authorities had reassured cases of myocarditis and pericarditis. Chief Public Health Officer, theresa tamo, emphasized that the benefits of vaccines mRNA The risks of myocarditis or pericarditis are greater. “I want to let Canadians know that the benefits of COVID-19 mRNA vaccines outweigh their potential risks. It is important that everyone gets a second dose of the vaccine to get the best possible protection.” he announced.